Legal & General Group Plc Buys 5,672 Shares of Mettler-Toledo International, Inc. $MTD

Legal & General Group Plc boosted its stake in Mettler-Toledo International, Inc. (NYSE:MTD) by 3.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 169,256 shares of the medical instruments supplier’s stock after purchasing an additional 5,672 shares during the quarter. Legal & General Group Plc owned about 0.82% of Mettler-Toledo International worth $207,780,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the stock. Versant Capital Management Inc grew its stake in shares of Mettler-Toledo International by 42.1% in the 3rd quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock valued at $33,000 after buying an additional 8 shares during the period. SJS Investment Consulting Inc. increased its position in Mettler-Toledo International by 2,700.0% in the 3rd quarter. SJS Investment Consulting Inc. now owns 28 shares of the medical instruments supplier’s stock valued at $34,000 after buying an additional 27 shares in the last quarter. MV Capital Management Inc. raised its stake in Mettler-Toledo International by 50.0% during the 2nd quarter. MV Capital Management Inc. now owns 36 shares of the medical instruments supplier’s stock worth $42,000 after buying an additional 12 shares during the period. Root Financial Partners LLC acquired a new position in Mettler-Toledo International during the 3rd quarter worth approximately $42,000. Finally, Salomon & Ludwin LLC bought a new position in Mettler-Toledo International in the third quarter worth approximately $43,000. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Price Performance

Shares of NYSE:MTD opened at $1,165.94 on Friday. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,525.17. The company has a market capitalization of $23.70 billion, a PE ratio of 27.68, a price-to-earnings-growth ratio of 2.58 and a beta of 1.43. The business has a fifty day moving average price of $1,383.26 and a two-hundred day moving average price of $1,368.76.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, February 5th. The medical instruments supplier reported $13.36 EPS for the quarter, topping analysts’ consensus estimates of $12.76 by $0.60. The company had revenue of $1.13 billion for the quarter, compared to analysts’ expectations of $1.10 billion. Mettler-Toledo International had a negative return on equity of 495.07% and a net margin of 21.59%.The business’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same period in the previous year, the business posted $12.41 EPS. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. Sell-side analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Insider Buying and Selling

In other Mettler-Toledo International news, CFO Shawn Vadala sold 800 shares of Mettler-Toledo International stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $1,410.12, for a total value of $1,128,096.00. Following the sale, the chief financial officer owned 5,288 shares of the company’s stock, valued at approximately $7,456,714.56. The trade was a 13.14% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 1.94% of the company’s stock.

Wall Street Analyst Weigh In

MTD has been the subject of a number of research reports. Bank of America raised Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price objective for the company in a research note on Monday, December 15th. Wells Fargo & Company upped their target price on Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the stock an “equal weight” rating in a research report on Monday, December 15th. Wall Street Zen upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Saturday, February 14th. Barclays reduced their price target on shares of Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating for the company in a research report on Monday, December 15th. Finally, Morgan Stanley decreased their price target on shares of Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating for the company in a research note on Tuesday, February 10th. Six equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $1,435.42.

Mettler-Toledo International Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.